Integral Health Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-200,000
Closed -$9.7M 96
2024
Q2
$9.7M Buy
+200,000
New +$9.65M 0.92% 35
2024
Q1
Sell
-400,000
Closed -$19.9M 92
2023
Q4
$19.9M Buy
+400,000
New +$19.6M 2.71% 8
2023
Q1
Sell
-200,000
Closed -$9.69M 87
2022
Q4
$9.69M Sell
200,000
-50,000
-20% -$2.19M 2.03% 20
2022
Q3
$9.51M Sell
250,000
-100,000
-29% -$4.46M 1.85% 21
2022
Q2
$17.5M Buy
+350,000
New +$18.6M 3.6% 5
2021
Q3
Sell
-175,000
Closed -$9.22M 85
2021
Q2
$9.22M Buy
+175,000
New +$9.13M 2.54% 11
2020
Q4
Sell
-125,000
Closed -$6.27M 82
2020
Q3
$6.27M Buy
+125,000
New +$6.44M 1.92% 17
2020
Q1
Sell
-190,000
Closed -$9.54M 72
2019
Q4
$9.54M Buy
+190,000
New +$8.9M 3.71% 6

Other funds holding SNY

Integral Health Asset Management's SNY Position: Q3 2024 in Review

Integral Health Asset Management sold out of Sanofi (SNY) in Q3 2024, closing a stake of 200,000 shares — an estimated $9.7M sold.

Integral Health Asset Management first reported a position in SNY in Q4 2019 and held it in 8 quarters. The position peaked at $19.9M in Q4 2023. 757 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

  • Integral Health Asset Management reported no remaining Sanofi position as of Q3 2024 after selling out during the quarter.
  • Integral Health Asset Management sold 200,000 Sanofi shares in Q3 2024, an estimated $9.7M.
  • Integral Health Asset Management first reported a position in Sanofi in Q4 2019 and held it in 8 quarters.
  • Integral Health Asset Management's Sanofi position peaked at $19.9M in Q4 2023.
  • 757 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on Integral Health Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.